What is the recommended management for vertebral artery disease?

Management of Vertebral Artery Disease

For patients with symptomatic vertebral artery disease, initiate immediate dual medical therapy with aspirin 75-325 mg daily and high-intensity statin (atorvastatin 80 mg) regardless of cholesterol levels, as this combination addresses the 10-15% annual stroke recurrence risk in the critical first weeks after symptom onset. 1, 2, 3

Immediate Risk Stratification and Diagnostic Workup

High-Risk Features Requiring Urgent Evaluation

• Patients presenting within 48 hours of posterior circulation symptoms (dizziness, vertigo, diplopia, ataxia, bilateral sensory deficits, perioral numbness, tinnitus) face highest stroke risk and require same-day stroke center assessment. 2, 4
• The 10% completed stroke risk within the first week applies specifically to transient posterior circulation symptoms, with peak danger in the initial 48 hours. 2
• Symptomatic vertebrobasilar disease managed with medical therapy alone carries 30% mortality at 2 years, distinguishing it from anterior circulation disease. 3

First-Line Imaging Protocol

• Order CTA from aortic arch to vertex as the initial study, providing 94% sensitivity and 95% specificity for vertebral artery stenosis and 100% sensitivity for dissection. 2, 4
• MRA is an acceptable alternative to CTA, but both are superior to duplex ultrasound (only 70% sensitivity) for vertebral artery evaluation. 1, 4
• Add MRI brain with diffusion-weighted imaging to detect silent posterior circulation infarcts that CT misses, particularly in brainstem, cerebellum, and thalami. 2, 4
• Reserve catheter-based digital subtraction angiography for patients being considered for revascularization when noninvasive imaging fails to define stenosis severity or location. 1, 2, 4

Mandatory Screening Populations

• Screen patients with asymptomatic bilateral carotid occlusions for vertebral artery disease. 1, 4
• Screen patients with unilateral carotid occlusion plus incomplete circle of Willis, as they depend on vertebrobasilar flow. 1, 4

Medical Management Framework

Antiplatelet Therapy

• Start aspirin 75-325 mg daily immediately in all symptomatic patients unless contraindicated. 1, 2
• If aspirin is contraindicated by allergy (not active bleeding), substitute clopidogrel 75 mg daily or ticlopidine 250 mg twice daily. 1
• When angiographic thrombus is identified at the vertebral artery origin or extracranial portion, add anticoagulation for at least 3 months regardless of whether thrombolysis was used. 1

Aggressive Risk Factor Control

• Prescribe high-intensity statin therapy (atorvastatin 80 mg daily) immediately in all symptomatic patients, independent of baseline lipid levels. 2, 4
• Target aggressive blood pressure control, as hypertension management reduces stroke risk with strong evidence in older adults. 4
• Optimize diabetes management and enforce smoking cessation (5-year abstinence restores stroke risk to never-smoker baseline). 4

Surveillance Strategy

• Perform serial noninvasive imaging (CTA or MRA) at intervals similar to carotid revascularization protocols to assess atherosclerotic progression and detect new lesions. 1, 4

Revascularization Decision Algorithm

When to Consider Intervention

• Reserve endovascular or surgical revascularization for patients who fail maximal medical therapy and have recurrent symptoms despite optimal antiplatelet and statin therapy. 1, 5, 6
• Patients with hemodynamic compromise (symptoms provoked by head turning or positional changes) represent the highest-risk subgroup who may benefit from revascularization. 4, 5, 6

Procedural Risk Counseling

• Endovascular stenting carries 5.5% periprocedural neurological complication risk and 0.3% procedural mortality. 4
• Surgical reconstruction mortality ranges 0-4% for proximal vertebral artery and 2-8% for distal reconstructions, making it rarely indicated. 4
• Intracranial vertebrobasilar atherosclerosis should be managed medically due to high complication rates with stenting. 6

Critical Clinical Pitfalls to Avoid

Diagnostic Errors

• Do not dismiss positional symptoms (dizziness worsening with head turning, tinnitus changing with position) as psychogenic—these indicate real hemodynamic compromise in already-stenotic vessels. 2, 4
• Do not rely on non-contrast head CT alone, as it misses small brainstem and cerebellar infarcts that MRI detects. 4
• Do not use duplex ultrasound as the sole imaging modality, as it inadequately visualizes vertebral artery origins and has only 70% sensitivity. 1, 4

Treatment Errors

• Do not withhold IV alteplase within 4.5 hours if standard inclusion criteria are met—vertebral dissection is not a contraindication to thrombolysis. 7
• Do not pursue endovascular intervention as first-line therapy; the 2011 ACC/AHA/ASA guideline emphasizes that no randomized trials support revascularization over medical management. 1
• Do not delay anticoagulation when thrombus is angiographically documented at the vertebral origin—start immediately for 3 months minimum. 1

Special Populations

• In younger patients presenting with vertebral artery symptoms plus headache or neck pain, prioritize evaluation for dissection over atherosclerosis. 4, 7
• Measure bilateral arm blood pressures to detect subclavian steal (≥15 mmHg difference suggests proximal stenosis contributing to vertebrobasilar insufficiency). 2